$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Express delivery! Novartis c-Met inhibitor "capmatinib" applies for marketing in China
2025-10-19 11:44:20
Check Details
The efficacy of nivolumab in treating gastric cancer: is it an immune drug or a targeted drug?
2025-10-19 11:44:20
Check Details
What is the effect of nivolumab combined with chemotherapy? What drug should be used with chemotherapy?
2025-10-19 11:44:20
Check Details
Is gefitinib a targeted drug and is it effective?
2025-10-19 11:44:20
Check Details
What are the indications and pharmacological effects of erlotinib?
2025-10-19 11:44:20
Check Details
Is afatinib effective and how to take it?
2025-10-19 11:44:20
Check Details
Is it necessary to take afatinib for early stage lung cancer? What are the adverse reactions?
2025-10-19 11:44:20
Check Details
Afatinib is a targeted drug of several generations. What diseases does it mainly treat?
2025-10-19 11:44:20
Check Details
What diseases does Osimertinib treat and is it effective?
2025-10-19 11:44:20
Check Details
Is Dacomitinib effective? How much does it cost per bottle?
2025-10-19 11:44:20
Check Details
What is the difference between osimertinib and dacomitinib, which drug is more effective?
2025-10-19 11:44:20
Check Details
What causes diarrhea while taking dacomitinib and how to deal with it?
2025-10-19 11:44:20
Check Details
1
2
...
4114
4115
4116
4117
4118
4119
4120
...
4155
4156
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
2
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
3
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options
4
Trametinib & Dabrafenib in 2026: A Global Guide to Treating BRAF-Mutant Cancers
5
A Guide to Safely Stopping Mitotane: Why Tapering is Essential and How to Manage
6
Pemigatinib Efficacy: Significantly Improving Survival in FGFR2-Fusion Cholangiocarcinoma
7
Erlotinib: Targeting EGFR Mutations to Precisely Inhibit Non-Small Cell Lung Cancer Growth
8
Tofacitinib: The Role and Considerations of an Oral JAK Inhibitor in Autoimmune Disease Treatment
9
Tucatinib: Redefining the Treatment Landscape for HER2-Positive Cancers with High Selectivity
10
Complete Guide to Garsorasib Resistance Mechanisms and Follow-Up Treatments
11
Vemurafenib: An Oral Targeted Therapy for BRAF V600E-Mutant Melanoma
12
Vemurafenib: Precision Targeting of BRAF Mutation, Revolutionizing Melanoma Treatment